Press Releases

NEW YORK and RICHMOND, Va., Aug. 14, 2019 /PRNewswire/ -- Paragon Private Health, with offices in New York, NY and Richmond, VA has been named to the prestigious Inc. 5000 list of the fastest growing private companies in America.  They are the only concierge me

Poised for significant growth with extraction operations ramping upPhase II equipment to be commissioned in coming weeks alleviating capacity constraints in Canada LAVAL, QC, Aug. 14, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Corporation") (NASDAQ: NEPT) (TSX: NEP

DAVIS, Calif., Aug. 14, 2019 /PRNewswire/ -- Evolve BioSystems, Inc. today announced findings from a new study that identified healthy, breastfed U.S. infants have

PALO ALTO, Calif., Aug. 14, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today reported business highlights and financial results for the second quarter ended June 30, 2019."During the sec

STOCKHOLM, Aug. 14, 2019 /PRNewswire/ -- In April 2018, RayStation was selected as the treatment planning system for Heidelberg Ion Beam Therapy Center (HIT), which is the leading German facility for proton and carbon ion therapy and part of the Heidelberg University Hospital. An additional RayStation order for photon therapy was placed lat

IOWA CITY, Iowa and LOS ANGELES, Aug. 14, 2019 /PRNewswire/ -- Research teams at the University of Io

VANCOUVER, British Columbia, Aug. 14, 2019 /PRNewswire/ --  MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) ("MYM Nutraceuticals" or the "Company") is pleased to announce that the Company has transferred two of its experienced executives to assist in the launch of MYM International Brands Inc. ("International Brands"). The Company's CFO,

SAN FRANCISCO, Aug. 13, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Evolent Health, Inc. (NYSE: EVH) to the securities class action, Plymouth County Retirement System v. Evolent Health, Inc. et al., No. 1:19-cv-01031 pending in the U.S. District Court for the Eastern District of Virginia.

SOUTH SAN FRANCISCO, Calif., Aug. 13, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) today announced the pricing of its underwritten public offering of 8,035,715 shares of its common stock at a price to the public of $28.00 per share. In addition, the underwriters of the offering have been granted a 30-day option to p

DALLAS and COLUMBIA, Md., Aug. 13, 2019 /PRNewswire/ -- CRISP, the designated health information exchange (HIE) covering patients across Maryland and the District of Columbia, today announced the expansion of its technical integration with ADVault, Inc., the global le